Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Open: May 25, 13:30 PM 2012  
PRGO HLF AUXL PBH USNA LFVN 
 
 
  NYSE  7,543  9.329  Index Moved Down 



Processing
Collecting data for BNLB

Bond quote and profile

    
0.06
  
OTC EQUITY
 0.00   No Change   0.00%  

Diversification Suggestion

Use Bond to offset short term systematic risk or to hedge overall market volatility. The stock experiences little momentum. The pattern is not really predictable. Watch out for false signals

1 Month Beta ..........

3.38
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bond will likely underperform.
Bond Laboratories Inc. Large Beta
BNLB United States OTC BB
Bond Laboratories Inc.
 
Trade Bond
Current Valuation4.06 M
Shares Outstanding74.3 M
Revenue14.06 M
Gross Profit4.15 M
 United States NASDAQ   0.09 % Macroaxis: 0.09 Moved Up  
 
 United States SP 500   0.03 % Macroaxis: 0.03 Moved Up  
 
 thisGreen BNLB BNLB.OB agains markets  0.00 % No Change  
 United States NYSE   0.12 % Macroaxis: 0.12 Moved Down  
 

Bond Leadership

John Wilson CEO and President Director and President of Fusion Premium Energy Inc, MBA
Lewis Jaffe Chairman of the Board

Bond Price and Market Media

The median price of Bond for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 0.08 with a coefficient of variation of 14.58. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.08, and mean deviation of 0.01. The Stock did not receive any noticable media coverage during the period.
Bond         Market
Price Growth (%)
 
Timeline

Bond Summary

Bond Laboratories Inc. [BNLB] is traded as part of a regulated electronic trading service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 4.53 M. Bond Laboratories Inc. operates under Healthcare sector and is part of Drug Related Products industry. This company has 74.3 M outstanding shares.

Bond Liquidity

BOND LABORATORIE has accumulated about 887.11 K in cash with 495.98 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
The company has accumulated 437.09 K in total debt with debt to equity ratio (D/E) of 0.11 which may suggest the company is not taking enough advantage from borrowing. Bond Laboratories Inc. has Current Ratio of 2.11 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Discuss Bond quote and profile

       
       
    
    
Bond
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Bond Laboratories Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    

Promote Bond

    
Follow Bond with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Bond to your reader
 
Get social with Bond
 Get social with Bond 
Share Toggle social options for Bond
    

Add Bond to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

Bond Research Report

    
    

Bond Directors

Michael Abrams Chief Financial officer, Principal Accounting officer and Director, MBA

Bond Management

Scott Solcum Executive of Fusion Premium Energy Inc
Ryan Zink President of NDS Nutritional Products



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting